Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

被引：0
|
作者：
赵小利 [1 ]
机构：
[1] Instit Hemato & Blood Dis Hosp,CAMS & PUMC
来源：
China Medical Abstracts (Internal Medicine) | 2019年 / 36卷 / 03期
关键词：
AML; Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia;
D O I：
暂无
中图分类号：
R733.7 [白血病]; R551.3 [骨髓疾病];
学科分类号：
1002 ; 100201 ; 100214 ;
摘要：
Objective To assess the efficacy and toxicity of decitabine-based conditioning regimen in patients with myelodysplastic syndrome (MDS),acute myeloid leukemia secondary to MDS (MDS-AML) or chronic myelomonocytic leukemia (CMML). Methods From March
引用
下载
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity
    Eapen, Mary
    Brazauskas, Ruta
    Hemmer, Michael
    Perez, Waleska S.
    Steinert, Patricia
    Horowitz, Mary M.
    Deeg, H. Joachim
    BLOOD ADVANCES, 2018, 2 (16) : 2095 - 2103
  • [42] Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults
    Zandberg, Dan P.
    Huang, Ting-Ying
    Ke, Xuehua
    Baer, Maria R.
    Gore, Steven D.
    Smith, Sheila Weiss
    Davidoff, Amy J.
    HAEMATOLOGICA, 2013, 98 (04) : 584 - 590
  • [43] Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre
    Montalvao, A.
    LEUKEMIA RESEARCH, 2013, 37 : S159 - S160
  • [44] Childhood Myelodysplastic Syndrome: Focus on the Approach to Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia
    Loh, Mignon L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 357 - 362
  • [45] The COP regimen is not a feasible treatment for advanced, refractory chronic lymphocytic leukemia
    Itala, M
    Remes, K
    LEUKEMIA & LYMPHOMA, 1996, 23 (1-2) : 137 - 141
  • [46] Decitabine combined with HAAG regimen is an effective salvage treatment for advanced acute myeloid leukemia
    Wei, C.
    Zhengming, J.
    Xiaming, Z.
    Aining, S.
    Huiying, Q.
    Miao, M.
    Cao, J.
    Dandan, G.
    Depei, W.
    Xiaowen, T.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S393 - S393
  • [47] DECITABINE COMBINED WITH HAAG REGIMEN IS AN EFFECTIVE SALVAGE TREATMENT FOR ADVANCED ACUTE MYELOID LEUKEMIA
    Cui, W.
    Jin, Z.
    Sun, A.
    Qiu, H.
    Miao, M.
    Cao, J.
    Guo, D.
    Wu, D.
    Tang, X.
    HAEMATOLOGICA, 2017, 102 : 382 - 382
  • [48] Decitabine Combined with Haag Regimen Is an Effective Salvage Treatment for Advanced Acute Myeloid Leukemia
    Tang, XiaoWen
    Cui, Wei
    Jin, Zhengming
    Zhu, Xiaming
    Sun, Aining
    Qiu, Huiying
    Miao, Miao
    Cao, Jing
    Guo, Dandan
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [49] Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Savona, Michael R.
    McCloskey, James K.
    Griffiths, Elizabeth A.
    Yee, Karen W. L.
    Al-Kali, Aref
    Zeidan, Amer M.
    Deeg, H. Joachim
    Patel, Prapti A.
    Sabloff, Mitchell
    Keating, Mary-Margaret
    Kim-Hien Dao
    Zhu, Nancy
    Gabrail, Nashat
    Fazal, Salman
    Maly, Joseph
    Odenike, Olatoyosi
    Kantarjian, Hagop M.
    DeZern, Amy E.
    O'Connell, Casey L.
    Roboz, Gail J.
    Busque, Lambert
    Wells, Richard A.
    Amin, Harshad
    Randhawa, Jasleen K.
    Leber, Brian
    Hao, Yong
    Keer, Harold N.
    Azab, Mohammad
    Garcia-Manero, Guillermo
    BLOOD, 2020, 136
  • [50] Chronic myelomonocytic leukemia evolved from refractory anemia: The unusual course of a myelodysplastic syndrome
    Niscola, P.
    Tendas, A.
    Fratoni, S.
    Giovannini, M.
    Scaramucci, L.
    Catalano, G.
    De Fabritiis, P.
    LEUKEMIA RESEARCH, 2013, 37 : S42 - S42
12345